Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

Apr 19, 2015 1:30 PM - Apr 19, 2015 4:30 PM

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Tutorial 4: Dose Finding in Drug Development: Methods and Implementation

Overview

This course will discuss, and propose methods to address, key statistical issues leading to the problems currently observed in dose finding studies.  A review of basic multiple comparisons and modeling methods, will be included, as traditionally used in these studies. A unified strategy for designing and analyzing dose finding studies, denoted MCP-Mod, combining multiple comparisons and modeling, will be the focus of the course. MCP-Mod received a positive CHMP qualification opinion in January 2014, as an efficient statistical methodology for model-based design and analysis of phase II dose finding studies under model uncertainty. It will be discussed in detail, including a step-by-step description of its practical implementation. An extension of MCP-Mod will be described for count data, time-to-event endpoints as well as situations involving generalized non-linear models, linear and non-linear mixed effects models, and Cox proportional hazards models. A short reference will be made to another extension of the comprehensive multiple comparisons and modeling framework to confirmatory testing in dose-response studies using MCP-Mod. Case studies based on real clinical trials, together with concrete examples of code in R based on the Dose Finding package available on CRAN, will be used to illustrate the practical use of the methodology.

Instructors:
Frank Bretz, PhD
Global Head of Statistical Methodology
Novartis Pharma AG, Switzerland

Jose C. Pinheiro, PhD
Senior Director, Quantitative Decision Strategies
Janssen Research & Development, LLC, United States

Bjoern Bornkamp, PhD,
MSc Expert Statistical Methodologist - Integrated Information Sciences
Novartis Pharma AG, Switzerland

For more information on this tutorial please click here

Learning objectives

Upon completion of this course, participants should understand:

  • Discuss goals and characteristics of dose-finding trials including why traditional methods tend to lead to poor dose selection and dose-response estimation
  • Identify alternative approaches based on multiple comparisons and modeling for target dose selection and dose-response estimation
  • Describe key concepts of the MCP-Mod methodology including how to implement it in practice for designing and analyzing dose finding trials
  • State the capabilities of the Dose Finding R package and how to use its functions to implement the MCP-Mod methodology

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.